The role of neutrophil estrogen receptor status on maspin synthesis via nitric oxide production in human breast cancer

Journal of Breast Cancer

Volumn 15, Issue 2, 2012, Pages 181-188

  Bhattacharjee, Karabi Ganguly ^a   Bhattacharyya, Mau ^a   Halder, Umesh Chandra ^b   Jana, Pradipta ^a   Sinha, Asru K ^a  

^a Sinha Institute of Medical Science and Technology   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Breast neoplasms; Estrogen receptors; Maspin; Neutrophils; Nitric oxide

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MASPIN; METHEMOGLOBIN; NITRIC OXIDE;

ADULT; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUTROPHIL; PROTEIN BINDING; PROTEIN SYNTHESIS; SCATCHARD PLOT;

EID: 84865124920     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2012.15.2.181     Document Type: Article

References (20)

1. Schneider HP, Jackisch C. Potential benefits of estrogens and progestogens on breast cancer. Int J Fertil Womens Med 1998;43:278-85.
2. Beato M, Klug J. Steroid hormone receptors: an update. Hum Reprod Update 2000;6:225-36.
3. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-9.
4. Hojo T, Akiyama Y, Nagasaki K, Maruyama K, Kikuchi K, Ikeda T, et al. Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. Cancer Lett 2001;171:103-10.
5. Liu T, Pemberton PA, Robertson AD. Three-state unfolding and selfassociation of maspin, a tumor-suppressing serpin. J Biol Chem 1999; 274:29628-32.
6. Girish GV, Bhattacharya G, Sinha AK. The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer. J Cancer Res Clin Oncol 2006;132:389-98.
7. Tlaskalová-Hogenová H, Stépánková R. Development of antibody formation in germ-free and conventionally reared rabbits: the role of intestinal lymphoid tissue in antibody formation to E. coli antigens. Folia Biol (Praha) 1980;26:81-93.
8. Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by chemiluminescence. J Anal Toxicol 1982;6:148-52.
9. Klock JC, Bainton DF. Degranulation and abnormal bactericidal function of granulocytes procured by reversible adhesion to nylon wool. Blood 1976;48:149-61.
10. Cook L, Ross AM, Knight GB, Agnello V. Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity. J Clin Microbiol 2000;38:4326-31.
11. Zimmerman R, Paluch U, Sprinzl M, Neupert W. Cell-free synthesis of the mitochondrial ADP/ATP carrier protein of Neurospora crassa. Eur J Biochem 1979;99:247-52.
12. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol 1972;109:129-35.
13. Motomura K, Ishitobi M, Komoike Y, Koyama H, Nagase H, Inaji H, et al. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. Oncology 2010;79:55-61.
14. Kahn NN, Sinha AK. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase. J Biol Chem 1990;265:4976-81.
15. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949;51:660-72.
16. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 1988;85:8664-7.
17. Whiting KP, Restall CJ, Brain PF. Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci 2000;67:743-57.
18. Mauvais-Jarvis P, Kuttenn F, Gompel A. Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 1986;8:179-88.
19. Kiba T, Inamoto T, Nishimura T, Ueno M, Yanagihara K, Teramukai S, et al. The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery. BMC Cancer 2008;8:323.
20. Rochefort H, Glondu M, Sahla ME, Platet N, Garcia M. How to target estrogen receptor-negative breast cancer? Endocr Relat Cancer 2003; 10:261-6.